相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritis
Piet Geusens
Therapeutics and Clinical Risk Management (2016)
EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT
W. Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs
Timothy D. Warner et al.
LANCET (2008)
Introduction: from basic biology to therapeutic potential
Thomas J. Schnitzer
OSTEOARTHRITIS AND CARTILAGE (2008)
Nitric oxide and cardiovascular and renal effects
Leopoldo Raij
OSTEOARTHRITIS AND CARTILAGE (2008)
The chemical biology of nitric oxide - an outsider's reflections about its role in osteoarthritis
Martin Feelisch
OSTEOARTHRITIS AND CARTILAGE (2008)
Osteoarthritis and nitric oxide
Steven B. Abramson
OSTEOARTHRITIS AND CARTILAGE (2008)
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
W. Zhang et al.
OSTEOARTHRITIS AND CARTILAGE (2008)
New horizons and perspectives in the treatment of osteoarthritis
Francis Berenbaum
ARTHRITIS RESEARCH & THERAPY (2008)
Nitric oxide and cardiovascular effects: new insights in the role of nitric oxide for the management of osteoarthritis
Isla S. Mackenzie et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Nitric oxide in inflammation and pain associated with osteoarthritis
Steven B. Abramson
ARTHRITIS RESEARCH & THERAPY (2008)
Role of nitric oxide in the gastrointestinal tract
Angel Lanas
ARTHRITIS RESEARCH & THERAPY (2008)
Building a better aspirin: gaseous solutions to a century-old problem
J. L. Wallace
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer
David J. Kerr et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Use of nonsteroidal Antiinflammatory drugs an update for clinicians - A scientific statement from the American Heart Association
Elliott M. Antman et al.
CIRCULATION (2007)
Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison
Loren Laine et al.
LANCET (2007)
OARSI recommendations for the management of hip and knee osteoarthritis, Part I: Critical appraisal of existing treatment guidelines and systematic review of current research evidence
W. Zhang et al.
OSTEOARTHRITIS AND CARTILAGE (2007)
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison
Christopher P. Cannon et al.
LANCET (2006)
Cardiovascular risk and inhibition of cyclooxygenase - A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase
Patricia McGettigan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events - Meta-analysis of randomized trials
Jingjing Zhang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Primer: managing NSAID-induced ulcer complications-balancing gastrointestinal and cardiovascular risks
Francis K. L. Chan
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2006)
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
Patricia M. Kearney et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Practice pointer - Understanding the NSAID related risk of vascular events
HE Vonkeman et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events
AT Chan et al.
CIRCULATION (2006)
Update on guidelines for the treatment of chronic musculoskeletal pain
Thomas J. Schnitzer
CLINICAL RHEUMATOLOGY (2006)
Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of osteoarthritis of the knee
TJ Schnitzer et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2005)
Selective cyclooxygenase 2 inhibitors and cardiovascular events
DH Solomon
ARTHRITIS AND RHEUMATISM (2005)
AZD3582 increases heme oxygenase-1 expression and antioxidant activity in vascular endothelial and gastric mucosal cells
G Berndt et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
W Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
RS Bresalier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery
NA Nussmeier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention
SD Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis
LS Lohmander et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
A common pathway of nitric oxide release from AZD3582 and glyceryl trinitrate
G Berndt et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial
ME Farkouh et al.
LANCET (2004)
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial
TJ Schnitzer et al.
LANCET (2004)
The nitric oxide-releasing naproxen derivative displays cardioprotection in perfused rabbit heart submitted to ischemia-reperfusion
G Rossoni et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Nitric oxide (NO)-releasing naproxen (HCT-3012 [(S)-6-methoxy-α- methyl-2-naphthaleneacetic acid 4-(nitrooxy)butyl ester]) interactions with aspirin in gastric mucosa of arthritic rats reveal a role for aspirin-triggered lipoxin, prostaglandins, and NO in gastric protection
S Fiorucci et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)
KM Jordan et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
COX-2 and beyond: Approaches to prostaglandin inhibition in human disease
G FitzGerald
NATURE REVIEWS DRUG DISCOVERY (2003)
Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans
CJ Hawkey et al.
GUT (2003)
New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis
MC Hochberg
SEMINARS IN ARTHRITIS AND RHEUMATISM (2002)
Divergent effects of new cyclooxygenase inhibitors on gastric ulcer healing: Shifting the angiogenic balance
L Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
A critical appraisal of clinical practice guidelines for the treatment of lower-limb osteoarthritis
JN Pencharz et al.
ARTHRITIS RESEARCH (2002)
Vasorelaxant effects of a nitric oxide-releasing aspirin derivative in normotensive and hypertensive rats
MN Muscará et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
C Bombardier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs
T Brzozowski et al.
DIGESTIVE AND LIVER DISEASE (2000)
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis - The CLASS study: A randomized controlled trial
FE Silverstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation -: An overview of epidemiologic studies published in the 1990s
S Hernández-Díaz et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Wound collagen deposition in rats:: effects of an NO-NSAID and a selective COX-2 inhibitor
MN Muscará et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
分享论文
